Endurant Capital Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-16,447
| Closed | -$401K | – | 88 |
|
|
2019
Q1 | $401K | Sell |
16,447
-85,898
| -84% | -$2.09M | 0.16% | 61 |
|
|
2018
Q4 | $1.46M | Sell |
102,345
-10,355
| -9% | -$148K | 0.77% | 32 |
|
|
2018
Q3 | $1.71M | Buy |
112,700
+31,284
| +38% | +$476K | 0.76% | 36 |
|
|
2018
Q2 | $1.37M | Buy |
81,416
+10,016
| +14% | +$168K | 0.59% | 42 |
|
|
2018
Q1 | $1.17M | Buy |
71,400
+20,800
| +41% | +$339K | 0.44% | 51 |
|
|
2017
Q4 | $648K | Sell |
50,600
-40,400
| -44% | -$517K | 0.2% | 68 |
|
|
2017
Q3 | $1.12M | Buy |
91,000
+7,300
| +9% | +$89.8K | 0.34% | 64 |
|
|
2017
Q2 | $701K | Buy |
+83,700
| New | +$701K | 0.2% | 79 |
|
|
2017
Q1 | – | Sell |
-28,100
| Closed | -$247K | – | 101 |
|
|
2016
Q4 | $247K | Buy |
28,100
+18,100
| +181% | +$159K | 0.1% | 65 |
|
|
2016
Q3 | $68K | Buy |
+10,000
| New | +$68K | 0.03% | 96 |
|